Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy
Crossref DOI link: https://doi.org/10.1007/s00520-016-3126-1
Published Online: 2016-02-23
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, James
Udd, Kyle A.
Vidisheva, Aleksandra
Swift, Regina A.
Spektor, Tanya M.
Bravin, Eric
Ibrahim, Emad
Treisman, Jonathan
Masri, Mohammed
Berenson, James R.
Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A. (X05392)
Text and Data Mining valid from 2016-02-23